Megan Riley, PhD

Clinical and Epidemiology Scientist
GSK

Disclosure: GSK (Individual(s) Involved: Self): Employee

Presentation(s):

• 5 - How Does Frailty Impact the Efficacy, Reactogenicity, Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine? A Secondary Analysis of the ZOE-50 and ZOE-70 Studies

  Oral Abstract